why Johnson & Johnson [JNJ] is a Good Choice for Investors After New Price Target of $184.21

Johnson & Johnson [NYSE: JNJ] traded at a high on 11/14/22, posting a 1.57 gain after which it closed the day’ session at $171.91. The company report on November 1, 2022 that Johnson & Johnson to Acquire Abiomed.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Strengthens Johnson & Johnson’s MedTech Business with the Addition of Abiomed, a World-Leader in Heart Recovery.

Transaction to Bring Lifesaving Innovations to More Patients with Unmet Need.

The results of the trading session contributed to over 6567242 shares changing hands. Over the past one week, the price volatility of Johnson & Johnson stands at 2.03% while the volatility over the past one month is 1.75%.

The market cap for JNJ stock reached $463.32 billion, with 2.63 billion shares outstanding and 2.61 billion shares in the current float. Compared to the average trading volume of 7.29M shares, JNJ reached a trading volume of 6567242 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Johnson & Johnson [JNJ]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for JNJ shares is $184.21 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on JNJ stock is a recommendation set at 2.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Barclays have made an estimate for Johnson & Johnson shares, keeping their opinion on the stock as Equal Weight, with their previous recommendation back on October 18, 2022. While these analysts kept the previous recommendation, BofA Securities dropped their target price from $185 to $178. The new note on the price target was released on October 14, 2022, representing the official price target for Johnson & Johnson stock.

The Average True Range (ATR) for Johnson & Johnson is set at 3.28, with the Price to Sales ratio for JNJ stock in the period of the last 12 months amounting to 4.82. The Price to Book ratio for the last quarter was 6.06, with the Price to Cash per share for the same quarter was set at 12.64. Price to Free Cash Flow for JNJ in the course of the last twelve months was 74.49 with Quick ratio for the last quarter at 1.20.

How has JNJ stock performed recently?

Johnson & Johnson [JNJ] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.62. With this latest performance, JNJ shares gained by 4.53% in over the last four-week period, additionally sinking by -3.46% over the last 6 months – not to mention a rise of 4.18% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for JNJ stock in for the last two-week period is set at 54.29, with the RSI for the last a single of trading hit 52.73, and the three-weeks RSI is set at 54.33 for Johnson & Johnson [JNJ]. The present Moving Average for the last 50 days of trading for this stock 167.06, while it was recorded at 172.38 for the last single week of trading, and 172.14 for the last 200 days.

Johnson & Johnson [JNJ]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Johnson & Johnson [JNJ] shares currently have an operating margin of +26.11 and a Gross Margin at +68.14. Johnson & Johnson’s Net Margin is presently recorded at +22.27.

Return on Equity for this stock inclined to 30.41, with Return on Assets sitting at 11.70.

Johnson & Johnson’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.20 and a Current Ratio set at 1.40.

Earnings analysis for Johnson & Johnson [JNJ]

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for JNJ. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Johnson & Johnson go to 3.90%.

Insider trade positions for Johnson & Johnson [JNJ]

There are presently around $312,787 million, or 71.20% of JNJ stock, in the hands of institutional investors. The top three institutional holders of JNJ stocks are: VANGUARD GROUP INC with ownership of 245,340,875, which is approximately 1.161% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 199,892,348 shares of the stock with an approximate value of $34.36 billion in JNJ stocks shares; and STATE STREET CORP, currently with $24.25 billion in JNJ stock with ownership of nearly -0.804% of the company’s market capitalization.

Positions in Johnson & Johnson stocks held by institutional investors increased at the end of October and at the time of the October reporting period, where 1,793 institutional holders increased their position in Johnson & Johnson [NYSE:JNJ] by around 41,678,395 shares. Additionally, 1,589 investors decreased positions by around 52,456,009 shares, while 374 investors held positions by with 1,725,347,050 shares. The mentioned changes placed institutional holdings at 1,819,481,454 shares, according to the latest SEC report filing. JNJ stock had 107 new institutional investments in for a total of 3,720,398 shares, while 125 institutional investors sold positions of 4,256,301 shares during the same period.


Please enter your comment!
Please enter your name here